351 related articles for article (PubMed ID: 11719835)
21. Acute Charcot arthropathy successfully treated with pamidronate: long-term follow-up.
Naqvi A; Cuchacovich R; Saketkoo L; Espinoza LR
Am J Med Sci; 2008 Feb; 335(2):145-8. PubMed ID: 18277124
[TBL] [Abstract][Full Text] [Related]
22. Charcot neuroarthropathy: An often overlooked complication of diabetes.
Botek G; Anderson MA; Taylor R
Cleve Clin J Med; 2010 Sep; 77(9):593-9. PubMed ID: 20810870
[TBL] [Abstract][Full Text] [Related]
23. Pamidronate in the prevention of bone loss after liver transplantation: a randomized controlled trial.
Monegal A; Guañabens N; Suárez MJ; Suárez F; Clemente G; García-González M; De la Mata M; Serrano T; Casafont F; Tome S; Barrios C; Navasa M
Transpl Int; 2009 Feb; 22(2):198-206. PubMed ID: 18796000
[TBL] [Abstract][Full Text] [Related]
24. Effect of pamidronate in preventing local bone loss after total hip arthroplasty: a randomized, double-blind, controlled trial.
Wilkinson JM; Stockley I; Peel NF; Hamer AJ; Elson RA; Barrington NA; Eastell R
J Bone Miner Res; 2001 Mar; 16(3):556-64. PubMed ID: 11277274
[TBL] [Abstract][Full Text] [Related]
25. Effect of pamidronate on excretion of pyridinium crosslinks of collagen after total hip arthroplasty.
Wilkinson JM; Jackson B; Eastell R
Calcif Tissue Int; 2003 Oct; 73(4):326-31. PubMed ID: 12874697
[TBL] [Abstract][Full Text] [Related]
26. Charcot neuroarthropathy in diabetes mellitus.
Rajbhandari SM; Jenkins RC; Davies C; Tesfaye S
Diabetologia; 2002 Aug; 45(8):1085-96. PubMed ID: 12189438
[TBL] [Abstract][Full Text] [Related]
27. Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.
De Jager J; Kooy A; Lehert P; Bets D; Wulffelé MG; Teerlink T; Scheffer PG; Schalkwijk CG; Donker AJ; Stehouwer CD
J Intern Med; 2005 Jan; 257(1):100-9. PubMed ID: 15606381
[TBL] [Abstract][Full Text] [Related]
28. A Surgeon's guide to advances in the pharmacological management of acute Charcot neuroarthropathy.
Al-Nammari SS; Timothy T; Afsie S
Foot Ankle Surg; 2013 Dec; 19(4):212-7. PubMed ID: 24095226
[TBL] [Abstract][Full Text] [Related]
29. A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of bone.
Walsh JP; Ward LC; Stewart GO; Will RK; Criddle RA; Prince RL; Stuckey BG; Dhaliwal SS; Bhagat CI; Retallack RW; Kent GN; Drury PJ; Vasikaran S; Gutteridge DH
Bone; 2004 Apr; 34(4):747-54. PubMed ID: 15050907
[TBL] [Abstract][Full Text] [Related]
30. Changes in thermal sensation in diabetic patients after treatment with gangliosides.
Abraham RR; Levy DM; Abraham RM
Diabetes Res; 1988 Mar; 7(3):129-35. PubMed ID: 3046820
[TBL] [Abstract][Full Text] [Related]
31. Oral administration of the growth hormone secretagogue MK-677 increases markers of bone turnover in healthy and functionally impaired elderly adults. The MK-677 Study Group.
Murphy MG; Bach MA; Plotkin D; Bolognese J; Ng J; Krupa D; Cerchio K; Gertz BJ
J Bone Miner Res; 1999 Jul; 14(7):1182-8. PubMed ID: 10404019
[TBL] [Abstract][Full Text] [Related]
32. Role of body mass index in acute charcot neuroarthropathy.
Ross AJ; Mendicino RW; Catanzariti AR
J Foot Ankle Surg; 2013; 52(1):6-8. PubMed ID: 23260985
[TBL] [Abstract][Full Text] [Related]
33. Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study.
Schwartz SL; Ratner RE; Kim DD; Qu Y; Fechner LL; Lenox SM; Holcombe JH
Clin Ther; 2008 May; 30(5):858-67. PubMed ID: 18555933
[TBL] [Abstract][Full Text] [Related]
34. Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease.
Reid IR; Miller P; Lyles K; Fraser W; Brown JP; Saidi Y; Mesenbrink P; Su G; Pak J; Zelenakas K; Luchi M; Richardson P; Hosking D
N Engl J Med; 2005 Sep; 353(9):898-908. PubMed ID: 16135834
[TBL] [Abstract][Full Text] [Related]
35. Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.
Boutsen Y; Jamart J; Esselinckx W; Devogelaer JP
J Bone Miner Res; 2001 Jan; 16(1):104-12. PubMed ID: 11149473
[TBL] [Abstract][Full Text] [Related]
36. Changes in calcium homoeostasis in patients undergoing liver transplantation: effects of a single infusion of pamidronate administered pre-operatively.
Bishop NJ; Ninkovic M; Alexander GJ; Holmes SD; Milligan T; Price C; Compston JE
Clin Sci (Lond); 1999 Aug; 97(2):157-63. PubMed ID: 10409470
[TBL] [Abstract][Full Text] [Related]
37. Infrared dermal thermometry is highly reliable in the assessment of patients with Charcot neuroarthropathy.
Dallimore SM; Puli N; Kim D; Kaminski MR
J Foot Ankle Res; 2020 Sep; 13(1):56. PubMed ID: 32928270
[TBL] [Abstract][Full Text] [Related]
38. Selective neuropathy and preserved vascular responses in the diabetic Charcot foot.
Stevens MJ; Edmonds ME; Foster AV; Watkins PJ
Diabetologia; 1992 Feb; 35(2):148-54. PubMed ID: 1547919
[TBL] [Abstract][Full Text] [Related]
39. Autoantibodies to post-translationally modified type I and II collagen in Charcot neuroarthropathy in subjects with type 2 diabetes mellitus.
Rizzo P; Pitocco D; Zaccardi F; Di Stasio E; Strollo R; Rizzi A; Scavone G; Costantini F; Galli M; Tinelli G; Flex A; Caputo S; Pozzilli P; Landolfi R; Ghirlanda G; Nissim A
Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27454862
[TBL] [Abstract][Full Text] [Related]
40. Triggering mechanisms of neuroarthropathy following conservative surgery for osteomyelitis.
Aragón-Sánchez J; Lázaro-Martínez JL; Hernández-Herrero MJ
Diabet Med; 2010 Jul; 27(7):844-7. PubMed ID: 20636967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
